Key takeaways:
Fatty liver disease is common. It’s caused by fat buildup in the liver.
Certain health conditions, such as obesity and Type 2 diabetes, increase the risk of fatty liver.
Fatty liver disease is treatable (and even reversible) if lifestyle changes are made early on.
The liver is busy. It performs more than 500 different functions, such as producing proteins and metabolizing medications. Because your liver has so many jobs, it’s important to keep it healthy. You might know that alcohol and certain infections (like hepatitis) can harm the liver, but you might not be aware that fat can damage it, too.
Fatty liver disease is exactly what it sounds like — fat buildup in the liver, causing problems. The formal term for fatty liver disease is “nonalcoholic fatty-liver disease” (NAFLD). When the fat buildup also causes inflammation, it’s called “nonalcoholic steatohepatitis” (NASH). The “nonalcoholic” part just means that the condition wasn’t caused by drinking alcohol, which can also lead to fat buildup and inflammation in the liver.
Fatty liver disease is very common. It affects over 25% of adults and anywhere from 7% to 34% of kids in the U.S. The good news? There’s a lot that can be done to prevent and even reverse the disease, if it’s caught early.
Fatty liver disease is caused by a buildup of extra fat in the liver, but we aren’t exactly sure what causes that buildup. We know that having extra body fat increases the risk, and the way a person’s body processes sugars and fats might have something to do with it, too.
Certain genes also increase the chances of developing fatty liver disease. For instance, the condition is more common in Hispanic people than in other racial groups.
Additional risk factors for fatty liver disease include:
A body mass index (BMI) greater than 25: Up to 75% of people who are overweight and more than 90% of people with obesity also have NAFLD.
Larger waist size: Similar to BMI, increased waist circumference has been linked to NAFLD.
Type 2 diabetes: At least 50% of people with Type 2 diabetes have NAFLD.
Metabolic syndrome: This condition is typically a combination of cholesterol problems, high blood pressure, increased waist size, and/or high blood sugars.
Sort of. No specific foods directly cause fat buildup in the liver, but making smart choices about what you eat and drink can help you to maintain a healthy weight and avoid metabolic syndrome. Exercise has also been shown to protect against fatty liver disease. So while this disease isn’t caused by any specific foods, lifestyle choices in general can contribute.
The difference is whether or not there’s inflammation in the liver.
In NAFLD, there’s too much fat in the liver, but it’s not swollen or inflamed. In NASH, the extra fat causes swelling and inflammation.
NASH is more severe, and more dangerous, because inflammation increases the risk of scarring in the liver. Both NAFLD and NASH can cause serious complications (see below), but the risk is higher with NASH. Fortunately, NASH is less common than NAFLD, affecting only 1.5% to 6.5% of people in the U.S.
Most people with fatty liver disease don’t have any symptoms.
Symptoms typically occur only in people who have severe or long-standing liver disease.
When symptoms do occur, they can include:
Yellowing of the skin or eyes (jaundice)
Nausea and/or vomiting
Fatigue and weakness
Weight loss and loss of appetite
Pain in the upper-right side of the abdomen
Itching
Spider angiomas (dilated, spider-like blood vessels on the chest)
Confusion
Note that many of these symptoms can be tied to a variety of conditions that affect the liver. They are not specific to fatty liver disease.
Since most people with fatty liver disease don’t have symptoms, it’s often discovered by accident, when tests are ordered for other reasons. For example, routine blood tests might show an elevation in the liver enzymes AST and ALT. In order to figure out why ALT and AST are elevated, your provider may order imaging tests (such as an ultrasound), which can reveal fat in the liver.
Fat in the liver confirms the diagnosis of fatty liver disease. Next, it’s important to determine if the liver is just fatty (NAFLD), or fatty and inflamed (NASH). But that isn’t always a straightforward process.
In many cases, the question can be answered by a liver biopsy — a procedure that involves removing a small piece of the liver with a needle and looking at it under a microscope. But liver biopsies are invasive, and not everyone needs one. Other tests may be more appropriate. Together with your provider, you can determine the best tests to get the answers you need.
Treatment for NAFLD involves diet changes and exercise. If changes are made early — before liver inflammation or scarring occur — fatty liver can be reversed.
These steps can help reverse or prevent fatty liver disease:
Taking care of other health conditions, such as diabetes
Improvement depends on how advanced the liver disease is at diagnosis and whether you have other health problems.
If left untreated, NAFLD and NASH can lead to serious complications, including liver failure (cirrhosis) and liver cancer. These risks are higher with NASH.
Fatty liver disease is common, and it can be dangerous. It doesn’t usually cause symptoms, so it’s important to know the risk factors. With a healthy lifestyle, you can prevent fatty liver, and even reverse it. And healthy changes to your diet and exercise routine will have positive effects on other aspects of your health as well.
American College of Gastroenterology. (2012). Non-alcoholic fatty liver disease (NAFLD).
American Liver Foundation. (2022). Nonalcoholic fatty liver disease (NAFLD).
Anderson, E. L., et al. (2015). The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis. PLoS One.
Chalasani, N., et al. (2017). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology.
John Hopkins Medicine. (n.d.). Ascites.
John Hopkins Medicine. (n.d.). Liver: Anatomy and functions.
John Hopkins Medicine. (n.d.). Liver biopsy.
Lee, Y., et al. (2019). Nonalcoholic fatty liver disease in diabetes. Part I: Epidemiology and diagnosis. Diabetes and Metabolism Journal.
Machado, M., et al. (2006). Hepatic histology in obese patients undergoing bariatric surgery. Journal of Hepatology.
National Institute for Health and Care Excellence. (2016). Diagnosis of NAFLD. Non-Alcoholic Fatty Liver Disease: Assessment and Management.
Rocha, R., et al. (2005). Body mass index and waist circumference in non-alcoholic fatty liver disease. Journal of Human Nutrition and Dietetics: The Official Journal of the British Dietetic Association.
Samji, N. S., et al. (2020). Racial disparities in diagnosis and prognosis of nonalcoholic fatty liver disease. Clinical Liver Disease.
Science Daily. (2021). How regular exercise can protect against fatty liver associated diseases.
Younossi, Z. M., et al. (2015). Global epidemiology of nonalcoholic fatty liver disease– Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology.